1692 related articles for article (PubMed ID: 19672092)
41. Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study.
Chen F; Hong H; Sun Y; Hu X; Zhang J; Xu G; Zhao W; Li H; Shi J
Ann Allergy Asthma Immunol; 2017 Oct; 119(4):310-316.e2. PubMed ID: 28870448
[TBL] [Abstract][Full Text] [Related]
42. Regulation and characterization of IL-17A expression in patients with chronic rhinosinusitis and its relationship with eosinophilic inflammation.
Makihara S; Okano M; Fujiwara T; Kariya S; Noda Y; Higaki T; Nishizaki K
J Allergy Clin Immunol; 2010 Aug; 126(2):397-400, 400.e1-11. PubMed ID: 20621345
[No Abstract] [Full Text] [Related]
43. The role of superantigens in chronic rhinosinusitis with nasal polyps.
Wang M; Shi P; Chen B; Zhang H; Jian J; Chen X; Wang Z; Zhang D
ORL J Otorhinolaryngol Relat Spec; 2008; 70(2):97-103. PubMed ID: 18408407
[TBL] [Abstract][Full Text] [Related]
44. Concentration, distribution and expression of interleukin-5 in human nasal polyp tissues.
Xu R; Li Y; Xie M; Xu G; Zhang G; Wang S
Chin Med J (Engl); 2002 Sep; 115(9):1386-9. PubMed ID: 12411119
[TBL] [Abstract][Full Text] [Related]
45. Clinical severity and epithelial endotypes in chronic rhinosinusitis.
Lam M; Hull L; McLachlan R; Snidvongs K; Chin D; Pratt E; Kalish L; Sacks R; Earls P; Sewell W; Harvey RJ
Int Forum Allergy Rhinol; 2013 Feb; 3(2):121-8. PubMed ID: 23038685
[TBL] [Abstract][Full Text] [Related]
46. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients.
Yao T; Kojima Y; Koyanagi A; Yokoi H; Saito T; Kawano K; Furukawa M; Kusunoki T; Ikeda K
Laryngoscope; 2009 Jun; 119(6):1053-9. PubMed ID: 19296494
[TBL] [Abstract][Full Text] [Related]
47. Differential expression of periostin in the nasal polyp may represent distinct histological features of chronic rhinosinusitis.
Shiono O; Sakuma Y; Komatsu M; Hirama M; Yamashita Y; Ishitoya J; Oridate N
Auris Nasus Larynx; 2015 Apr; 42(2):123-7. PubMed ID: 25270863
[TBL] [Abstract][Full Text] [Related]
48. [Expression and cellular provenance of interleukin 17A in non-eosinophilic chronic rhinosinusitis with nasal polyps].
Chen XH; Chang LH; Huang JC; Li X; Lai XP; Wu XF; Huang ZZ; Wang ZY; Bao HW; Zhang GH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jun; 55(6):604-610. PubMed ID: 32610404
[No Abstract] [Full Text] [Related]
49. The role of interleukin-33 in chronic rhinosinusitis.
Kim DK; Jin HR; Eun KM; Mo JH; Cho SH; Oh S; Cho D; Kim DW
Thorax; 2017 Jul; 72(7):635-645. PubMed ID: 27885166
[TBL] [Abstract][Full Text] [Related]
50. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma.
Ediger D; Sin BA; Heper A; Anadolu Y; Misirligil Z
Clin Exp Allergy; 2005 Mar; 35(3):319-26. PubMed ID: 15784110
[TBL] [Abstract][Full Text] [Related]
51. Expression of IL-25, IL-33, and Thymic Stromal Lymphopoietin in Nasal Polyp Gland Duct Epithelium in Patients With Chronic Rhinosinusitis.
Nagata Y; Maruoka S; Gon Y; Mizumura K; Kishi H; Nomura Y; Hikichi M; Hashimoto S; Oshima T
Am J Rhinol Allergy; 2019 Jul; 33(4):378-387. PubMed ID: 30873846
[No Abstract] [Full Text] [Related]
52. Expression and characterization of PGD2 receptors in chronic rhinosinusitis: modulation of DP and CRTH2 by PGD2.
Yamamoto M; Okano M; Fujiwara T; Kariya S; Higaki T; Nagatsuka H; Tsujigiwa H; Yamada M; Yoshino T; Urade Y; Nishizaki K
Int Arch Allergy Immunol; 2009; 148(2):127-36. PubMed ID: 18802357
[TBL] [Abstract][Full Text] [Related]
53. Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis.
Ishida A; Ohta N; Suzuki Y; Kakehata S; Okubo K; Ikeda H; Shiraishi H; Izuhara K
Allergol Int; 2012 Dec; 61(4):589-95. PubMed ID: 22918213
[TBL] [Abstract][Full Text] [Related]
54. Vascular endothelial growth factor and children featuring nasal polyps.
Hu KH; Lee FP; Cheng YJ; Huang HM
Int J Pediatr Otorhinolaryngol; 2007 Jan; 71(1):23-8. PubMed ID: 16987554
[TBL] [Abstract][Full Text] [Related]
55. Immunomodulatory effect of cytosine-phosphate-guanosine (CpG)-oligonucleotides in nonasthmatic chronic rhinosinusitis: an explant model.
Tan L; Rogers TJ; Hatzirodos N; Baker LM; Ooi E; Wormald PJ
Am J Rhinol Allergy; 2009; 23(2):123-9. PubMed ID: 19401034
[TBL] [Abstract][Full Text] [Related]
56. Immune profile modulation of blood and mucosal eosinophils in nasal polyposis with concomitant asthma.
Mortuaire G; Gengler I; Vandenhende-Szymanski C; Delbeke M; Gatault S; Chevalier D; Prin L; Capron M
Ann Allergy Asthma Immunol; 2015 Apr; 114(4):299-307.e2. PubMed ID: 25704963
[TBL] [Abstract][Full Text] [Related]
57. Staphylococcal protein A-formulated immune complexes suppress enterotoxin-induced cellular responses in nasal polyps.
Okano M; Fujiwara T; Kariya S; Haruna T; Higaki T; Noyama Y; Makihara S; Kanai K; Nishizaki K
J Allergy Clin Immunol; 2015 Aug; 136(2):343-50.e8. PubMed ID: 25724120
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-25 and mucosal T cells in noneosinophilic and eosinophilic chronic rhinosinusitis.
Iinuma T; Okamoto Y; Yamamoto H; Inamine-Sasaki A; Ohki Y; Sakurai T; Funakoshi U; Yonekura S; Sakurai D; Hirahara K; Nakayama T
Ann Allergy Asthma Immunol; 2015 Apr; 114(4):289-98. PubMed ID: 25704964
[TBL] [Abstract][Full Text] [Related]
59. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.
Pothoven KL; Norton JE; Hulse KE; Suh LA; Carter RG; Rocci E; Harris KE; Shintani-Smith S; Conley DB; Chandra RK; Liu MC; Kato A; Gonsalves N; Grammer LC; Peters AT; Kern RC; Bryce PJ; Tan BK; Schleimer RP
J Allergy Clin Immunol; 2015 Sep; 136(3):737-746.e4. PubMed ID: 25840724
[TBL] [Abstract][Full Text] [Related]
60. Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma.
Stankovic KM; Goldsztein H; Reh DD; Platt MP; Metson R
Laryngoscope; 2008 May; 118(5):881-9. PubMed ID: 18391768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
